ERVW-1 and HIV-1 infection: The CD4-CCR5 fusion mimetics demonstrated improved binding to Env trimers, neutralized a wider panel of HIV-1 isolates, and were less efficient in promoting HIV-1 infection in CCR5+/CD4− cells as compared with CD4-mimetics.